Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$33.11 - $55.01 $66 - $110
-2 Reduced 3.57%
54 $2,000
Q2 2021

Aug 17, 2021

BUY
$56.61 - $80.46 $1,245 - $1,770
22 Added 64.71%
56 $4,000
Q1 2021

May 17, 2021

SELL
$86.23 - $125.19 $258 - $375
-3 Reduced 8.11%
34 $3,000
Q4 2020

Feb 16, 2021

SELL
$79.17 - $111.47 $2,137 - $3,009
-27 Reduced 42.19%
37 $3,000
Q3 2020

Nov 12, 2020

BUY
$81.91 - $134.94 $5,242 - $8,636
64 New
64 $7,000

Others Institutions Holding EBS

About Emergent BioSolutions Inc.


  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $289M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Carolinas Wealth Consulting LLC Portfolio

Follow Carolinas Wealth Consulting LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Carolinas Wealth Consulting LLC, based on Form 13F filings with the SEC.

News

Stay updated on Carolinas Wealth Consulting LLC with notifications on news.